Level Chart

Basic Info

Gilead Sciences Inc (GILD) - Royalty, Contract and Other Revenue is at a current level of 424.00M, up from 27.00M last quarter and up from 30.00M one year ago. This is a change of 1.47K% from last quarter and 1.31K% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 424.00M
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:08 EST
Next Release Jan 30 2026, 08:30 EST (E)
Average Growth Rate 259.4%
Value from Last Quarter 27.00M
Change from Last Quarter 1.47K%
Value from 1 Year Ago 30.00M
Change from 1 Year Ago 1.31K%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File Upgrade

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2025 424.00M
June 30, 2025 27.00M
March 31, 2025 54.00M
December 31, 2024 33.00M
September 30, 2024 30.00M
June 30, 2024 41.00M
March 31, 2024 39.00M
December 31, 2023 45.00M
September 30, 2023 56.00M
June 30, 2023 35.00M
March 31, 2023 46.00M
December 31, 2022 56.00M
Date Value
September 30, 2022 64.00M
June 30, 2022 122.00M
March 31, 2022 56.00M
December 31, 2021 84.00M
September 30, 2021 65.00M
June 30, 2021 65.00M
March 31, 2021 83.00M
December 31, 2020 93.00M
September 30, 2020 84.00M
June 30, 2020 76.00M
March 31, 2020 81.00M
December 31, 2019 83.00M

Basic Info

Gilead Sciences Inc (GILD) - Royalty, Contract and Other Revenue is at a current level of 424.00M, up from 27.00M last quarter and up from 30.00M one year ago. This is a change of 1.47K% from last quarter and 1.31K% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 424.00M
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:08 EST
Next Release Jan 30 2026, 08:30 EST (E)
Average Growth Rate 259.4%
Value from Last Quarter 27.00M
Change from Last Quarter 1.47K%
Value from 1 Year Ago 30.00M
Change from 1 Year Ago 1.31K%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File Upgrade

Related Securities

Symbol Name Change %
GILD Gilead Sciences, Inc. -0.36%